glp-1 weight loss drug With FDA approval of Wegovy pill, new era of oral drugs begins Chart: 1 in 8 Americans
Description
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes
Suggested Use
Curious about GLP-1 medications like Ozempic and Wegovy
Encourages Lasting Weight Balance Built to promote steady, consistent progress rather than temporary fixes
Promotes Lean Muscle & Fat Reduction*
